Shares of Faron Pharmaceuticals Oy (LON:FARN – Get Free Report) crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of GBX 184.50 ($2.29) and traded as low as GBX 146 ($1.81). Faron Pharmaceuticals Oy shares last traded at GBX 170 ($2.11), with a volume of 134,879 shares traded.
Faron Pharmaceuticals Oy Trading Down 4.7 %
The company has a market capitalization of £169.48 million, a price-to-earnings ratio of -506.25 and a beta of 0.36. The company has a current ratio of 1.45, a quick ratio of 1.09 and a debt-to-equity ratio of 922.55. The business’s 50 day moving average price is GBX 184.38 and its two-hundred day moving average price is GBX 185.71.
About Faron Pharmaceuticals Oy
Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.
See Also
- Five stocks we like better than Faron Pharmaceuticals Oy
- How to Effectively Use the MarketBeat Ratings Screener
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
- Growth Stocks: What They Are, What They Are Not
- Why New Tariffs Could Boost These 3 Basic Materials Stocks
- Upcoming IPO Stock Lockup Period, Explained
- MarketBeat Week in Review – 02/03 – 02/07
Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.
